Canada’s cannabis producer MedReleaf has introduced new brand San Rafael ’71.

As part of the brand’s development and launch, MedReleaf has collaborated with Amsterdam Brewing Company to develop and introduce San Rafael ’71’s cannabis-based beer 4:20 Pale Ale.

“Our award-winning team created a flavour profile using a unique blend of citrus and summit hops and speciality malts that gives a nod to the cannabis experience.”

MedReleaf’s strategy vice-president Darren Karasiuk said: “While cannabis aficionados eagerly anticipate the day they can buy legal products, we thought we’d offer the San Rafael ’71 4:20 Pale Ale for them to enjoy while they wait.

“San Rafael ’71 4:20 Pale Ale does not contain any cannabis, but it will take you back to where it all began and introduce Canadians to the spirit of adventure, exploration and freedom at the heart of 4:20.”

The 4:20 Pale Ale offering is 4.2% alcohol-by-volume (ABV) and reaches 42 units on the International Bitterness Unit (IBU) scale.

Amsterdam Brewing CEO Jeff Carefoote said: “Our award-winning team created a flavour profile using a unique blend of citrus and summit hops and speciality malts that gives a nod to the cannabis experience with peach and pine aromas giving way to spice and mild bitterness.”

Packaged in 473ml cans, 4:20 Pale Ale will be available at The Beer Store on release.

MedReleaf CEO Neil Closner said: “4:20 is a defining symbol of cannabis culture and we wanted to celebrate and pay tribute to that history and inspiration.

“The launch of San Rafael ’71 is the first of many steps on this front, including a portfolio of brands and products that leverage the company’s award-winning product selection, quality and innovation.”